Phase 4 COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 80 years old, of any gender
- People who weigh at least 40 kg and have a body mass index (BMI) of 18 or above
- People who have been receiving kidney dialysis (either hemodialysis or peritoneal dialysis) for at least 3 months before joining
- People who have been taking medications called erythropoiesis-stimulating agents (ESAs) — drugs that help the body make red blood cells — for at least 4 weeks before the trial, at a dose above a certain level (confirm with trial site for exact dose details)
- People whose most recent blood test shows a haemoglobin level (a measure of red blood cells) between 70 and below 110 g/L during the screening period
- People on hemodialysis with a stored iron level (ferritin) of at least 200 μg/L, or people on peritoneal dialysis with a ferritin level of at least 100 μg/L, and for whom the treating doctor determines a kidney transplant is not needed during the trial period
- People who understand what the study involves and are willing to sign a consent form
Who may not be able to join:
- People known to have active cancer, polycystic kidney disease, blood disorders (such as thalassemia, haemolytic anaemia, or clotting disorders), or other identified causes of anaemia such as gastrointestinal bleeding
- People who have had a stroke, mini-stroke (TIA), heart attack, blood clots (such as deep vein thrombosis or pulmonary embolism), or other serious heart or lung conditions in the past 6 months
- People who have received anabolic steroid treatment (such as androgens) in the 12 weeks before the trial starts
- People who have received a red blood cell or whole blood transfusion in the 12 weeks before the trial starts
- People who have had a significant infection in the 4 weeks before the trial starts, as determined by the treating doctor
- People who have had consistently very high blood pressure readings (systolic at or above 180 mmHg and/or diastolic at or above 110 mmHg) on at least three separate days in the 4 weeks before joining, or who have recently had changes made to their blood pressure medications
- People with a known allergy to iron products or polyethylene glycol
- People who are pregnant, breastfeeding, have a positive pregnancy blood test before the trial, or are planning to become pregnant during the study period
- People who have a planned surgical procedure scheduled during the trial period
- People whom the treating doctor considers unsuitable for participation for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiangmei Chen, Chinese PLA General Hospital
Phone: +8615810136659
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The change in mean hemoglobin (Hb) levels from baseline at weeks 12 to 16 of treatment in the three groups.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.